Drug CEOs Switch Tactics on Reform
by admin on May.27, 2009, under Healthcare, News, Political
Drug CEOs Switch Tactics on Reform
Pharmaceutical Companies Join Health-Care Overhaul, Hoping to Influence Where Costs Are Cut
Drug-company executives are aiming to prevent steep cuts in prescription prices by joining the effort to overhaul the U.S. health-care system.
Their approach contrasts sharply with their behavior 15 years ago, when they helped defeat President Bill Clinton’s reform efforts from the outside. “This is not the 1990s, when the industry was playing defense,” says John Lechleiter, Eli Lilly & Co.’s chief executive. “We’re playing offense. We’re at the table.” click here for more
